shutterstock_2040062156.jpg
Accelerating nucleic acid therapeutics 

Our Mission

To develop nucleic acid therapeutics, through a blend of proprietary chemistry and novel biology, to solve unmet medical needs and improve lives.

About Us

Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases and targeting a variety of organs and tissues. 

With sites in Singapore, China and USA, Cargene leverages our chemistry and biological insights to deliver clinically meaningful treatments.

shutterstock_521610733.jpg

Meet Our Team

The Cargene management and scientific team comprises experienced biotech and life science professionals with diverse expertise ranging from research and development, business development, clinical affairs, manufacturing, and commercialization.